Adlai Nortye (ANL) Other Accumulated Expenses (2023 - 2025)
Adlai Nortye's (ANL) quarterly Other Accumulated Expenses came in at $4.9 million in Q2 2025, up 28.73% year-on-year from $3.8 million in Q2 2024, and up 42.95% on a QoQ basis from $3.4 million in Q4 2024.
Adlai Nortye (ANL) Other Accumulated Expenses (2023 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 3 years of Other Accumulated Expenses data on file, last reported at $4.9 million in Q2 2025.
- On a quarterly basis, Other Accumulated Expenses rose 28.73% year-over-year to $4.9 million in Q2 2025; TTM through Jun 2025 was $4.9 million, a 28.73% increase from a year earlier, with the FY2024 full-year figure at $3.4 million, down 30.2% from the prior year.
- Other Accumulated Expenses for Q2 2025 stood at $4.9 million, up from $3.4 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for ANL reached as high as $4.9 million in Q4 2023 and fell as low as $3.4 million in Q4 2024.
- Historically, Other Accumulated Expenses has averaged $4.2 million across 3 years, with a median of $4.3 million in 2024.
- Across the five-year window, Other Accumulated Expenses tumbled 30.2% in 2024 and increased 28.73% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $4.9 million in 2023, then tumbled by 30.2% to $3.4 million in 2024, then surged by 42.95% to $4.9 million in 2025.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $4.9 million in Q2 2025, $3.4 million in Q4 2024, and $3.8 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.88 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Jun 30, 2024 | 3.79 Mn |
| Dec 31, 2023 | 4.89 Mn |